Literature DB >> 11093723

Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review.

D Shouval1, D Samuel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11093723     DOI： 10.1053/jhep.2000.19789

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  40 in total

Review 1.  Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation.

Authors:  Li Jiang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

2.  Functional recombinant human anti-HBV antibody expressed in milk of transgenic mice.

Authors:  Ran Zhang; Dan Cui; Hong Wang; Chuan Li; Xin Yao; Yaofeng Zhao; Mifang Liang; Ning Li
Journal:  Transgenic Res       Date:  2012-10       Impact factor: 2.788

Review 3.  Hepatitis B virus infection in liver transplant candidates and recipients.

Authors:  Patrick Yachimski; Raymond T Chung
Journal:  MedGenMed       Date:  2005-04-18

4.  Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein.

Authors:  Mario Perotti; Nicasio Mancini; Roberta A Diotti; Alexander W Tarr; Jonathan K Ball; Ania Owsianka; R Adair; Arvind H Patel; Massimo Clementi; Roberto Burioni
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

5.  Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients.

Authors:  Joy Varghese; Mettu Srinivas Reddy; Thomas Cherian; Srinivasan Vijaya; Venkataraman Jayanthi; Mohamed Rela
Journal:  Indian J Gastroenterol       Date:  2014-04-24

Review 6.  Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation.

Authors:  Evangelos Cholongitas; George V Papatheodoridis
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

7.  Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells.

Authors:  Avidan U Neumann; Sandra Phillips; Idit Levine; Samreen Ijaz; Harel Dahari; Rachel Eren; Shlomo Dagan; Nikolai V Naoumov
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

8.  Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.

Authors:  Florian Bihl; Stefan Russmann; Vanina Gurtner; Loriana Di Giammarino; Loredana Pizzi-Bosman; Martine Michel; Andreas Cerny; Antoine Hadengue; Pietro Majno; Emiliano Giostra; Damiano Castelli; Gilles Mentha
Journal:  BMC Gastroenterol       Date:  2010-07-04       Impact factor: 3.067

Review 9.  Pre- and Post-Transplant Antiviral Therapy (HBV, HCV).

Authors:  Martin-Walter Welker; Stefan Zeuzem
Journal:  Visc Med       Date:  2016-04-08

Review 10.  Management of hepatitis B virus infection after liver transplantation.

Authors:  Miguel Jiménez-Pérez; Rocío González-Grande; José Mostazo Torres; Carolina González Arjona; Francisco Javier Rando-Muñoz
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.